DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?
Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma…
Author
A Mixed Bag of Reactions
Though the life sciences sector has stored some good points in Union Budget 2016, it has evoked a mixed response from industry…
Biocon in co-development and commercialisation agreement with Lab PiSA
The collaboration is part of Biocon’s strategy to address the large demand for generic rh-insulin in the US
Taro Pharma plans shares repurchase worth $250 million
The repurchase authorisation enables it to purchase it's ordinary shares from time to time through open market purchases
Orchid Pharma bags from USFDA for Parkinson’s drug
Orchid expects to launch this products in the fourth quarter of fiscal 2016-17
Signet-Meggle’s seminar on DPI held in Mumbai
The seminar provided in-depth information on DPI technology using properties of lactose powder
Lupin completes acquisition of GAVIS
The combined company will have a portfolio of over 120 in-market products, over 185 cumulative filings pending approval and a deep…
Merial and Zoetis in strategic agreement
Agreement expands Merial portfolio to include 15 new products, making it a key player in the dairy cattle market in India
Creating tomorrow’s pharma leaders
In the second article of his series on pharma leaders, Amogh Deshmukh, Member, Key Leadership Team, DDI India, speaks on managing…